Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. (Q34537906)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. |
scientific article |
Statements
1 reference
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. (English)
1 reference
Lucia Flores-Contreras
1 reference
Ana S Sandoval-Rodríguez
1 reference
Mayra G Mena-Enriquez
1 reference
Silvia Lucano-Landeros
1 reference
Inmaculada Arellano-Olivera
1 reference
Arnulfo Alvarez-Álvarez
1 reference
M Guadalupe Sanchez-Parada
1 reference
Juan Armendáriz-Borunda
1 reference
27 July 2014
1 reference
1 reference
14
1 reference
131
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference